Abstract
Primary progressive multiple sclerosis (PPMS) is clinically characterized by progression without remission or relapse, in contrast to relapsing forms of MS. Pathologic and imaging findings also indicate that PPMS differs from relapsing forms. Recent studies examining potential immunologic differences among MS forms suggest that cytokine and adhesion molecule expression profiles, but not chemokine receptor profiles, in PPMS patients resemble those in healthy controls more than those in patients with relapsing MS. However, the significance of these findings remains to be fully elucidated, and there is little additional evidence as yet of marked differences among MS forms based on immunologic characteristics. Of interest are the recent demonstrations that activated immune cells produce brain-derived neurotrophic factor (BDNF), a neuroprotective factor, in MS lesions, that BDNF receptors are located in MS tissue, and that glatiramer acetate (GA)-specific T cells produce BDNF irrespective of T helper cell Th1 or Th2 phenotype. These findings both support the concept of a protective inflammation in MS and suggest an additional mechanism of action for the clinical effects of GA therapy in MS. Whether and to what extent this mechanism ...Continue Reading
References
Mar 2, 1999·The Journal of Experimental Medicine·M KerschensteinerR Hohlfeld
Dec 3, 1999·Brain : a Journal of Neurology·I DuránX Montalban
Aug 10, 2000·The Journal of Experimental Medicine·H BabbeK Rajewsky
Sep 12, 2001·Neurology·J PeltolaI Elovaara
Nov 6, 2001·Journal of Neuroimmunology·A H van Boxel-DezaireL Nagelkerken
Nov 29, 2001·Multiple Sclerosis : Clinical and Laboratory Research·R EggT Berger
Feb 9, 2002·Brain : a Journal of Neurology·Christine StadelmannHans Lassmann
Oct 3, 2002·Multiple Sclerosis : Clinical and Laboratory Research·E M Martínez-CáceresX Montalban
Oct 23, 2002·Brain : a Journal of Neurology·Tjalf ZiemssenReinhard Hohlfeld
Feb 26, 2003·Annals of Neurology·Martin KerschensteinerReinhard Hohlfeld
Jul 11, 2003·The New England Journal of Medicine·Thomas BergerMarkus Reindl
Feb 26, 2004·Proceedings of the National Academy of Sciences of the United States of America·Christian SkulinaNorbert Goebels
Citations
Feb 14, 2012·Acta Neuropathologica·Jack AntelTanja Kuhlmann
Aug 13, 2009·Journal of Ocular Biology, Diseases, and Informatics·Ping HuangChun Zhang
Jan 5, 2010·Journal of Ocular Biology, Diseases, and Informatics·Ping HuangChun Zhang
Jan 16, 2008·CNS Drugs·Christopher ChristodoulouLauren B Krupp
Jun 26, 2012·Brain : a Journal of Neurology·Elaine KingwellHelen Tremlett
Dec 1, 2006·Clinical Neuroscience Research·Monica J CarsonBarbara Walter
Jun 6, 2006·Clinical Neurology and Neurosurgery·Ivana ZadroMarko Brinar
Nov 9, 2005·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Marcella CaggiulaMassimiliano Mirabella
Oct 19, 2005·Pharmacology & Therapeutics·Adil Javed, Anthony T Reder
Jul 26, 2005·Neuroscience Letters·Diego ScalabriniElio Scarpini
May 12, 2009·Neurobiology of Disease·Hayrettin TumaniUNKNOWN BioMS Study Group
Nov 17, 2010·Multiple Sclerosis : Clinical and Laboratory Research·Patrizia SolaElisa Merelli
Oct 3, 2009·Multiple Sclerosis : Clinical and Laboratory Research·X MontalbanA Rovira
Dec 10, 2009·Multiple Sclerosis : Clinical and Laboratory Research·X MontalbanA J Thompson
Oct 16, 2015·The Neurologist·Masoud MehrpourAlipasha Meysamie
Jan 29, 2019·Frontiers in Immunology·Hans Lassmann
Jun 17, 2021·Scientific Reports·Rosalía Gil-BernalCarmen Gómez-Gómez